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foreword
At the high-level segment of the fifty-second session of the Commission on Narcotic 
Drugs, held on 11 and 12 March 2009, Heads of State, ministers and government 
representatives from 132 States gathered to evaluate progress made since 1998 towards 
meeting the goals and targets established at the twentieth special session of the General 
Assembly, devoted to countering the world drug problem together; to identify future 
priorities and areas requiring further action and goals and targets to be established for 
drug control beyond 2009; and to adopt a political declaration and other measures to 
enhance international cooperation.
Member States adopted the Political Declaration and Plan of Action on International 
Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug 
Problem, which is contained in the present publication. 
The adoption of the Political Declaration and Plan of Action some 10 years after the 
twentieth special session of the General Assembly of 1998 has given fresh impetus to 
international drug control. It is now incumbent on Member States to follow up and 
implement those international commitments in order to enhance progress and thus 
address the challenges posed by the world drug problem effectively in the coming 
years.
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1statement by the united nations under-secretary-general 
and executive Director of the united nations office on Drugs 
and crime, mr. antonio maria costa, to the opening of the 
high-level segment of the commission on narcotic Drugs at 
its fifty-second session
This Session of the Commission on Narcotic Drugs coincides with the centenary of the 
Shanghai International Opium Commission (1909). It is also the opportunity to review 
progress made since the Special Session of the United Nations General Assembly 
(UNGASS in 1998) on drugs. 
The question in everybody’s mind is simple: have these multiple efforts reduced the 
world drug problem? Up front, let me report what the statistics say: if we look at the 
physical dimensions of the problem (tons of production and numbers of addicts), we 
can state that humanity has made measurable progress. If we look however at the bigger 
picture, namely at the impact of drugs on security and development, the assessment is 
more complex—and not benign. Let me explain how I see the situation and what can 
be done. 
measurably lower drug supply
Look first at supply. More than 40,000 tons of opium were produced a century ago. 
They are now down by three quarters, to 10,000 tons concentrated in Southern 
Afghanistan. Coca cultivation in the Andes is down by almost a fifth since 10 years ago 
(1999). In both regions illicit crops take place in areas infested by armed groups who 
protect, even promote the drug trade. 
Above all, in the past 10 years, we have learned what has to be done to curtail drug 
cultivation: (a) re-establish government control over the territory, so as to bring security; 
and (b) promote development, so as to eradicate poverty and not only drugs. The steep 
drop in opium cultivation in the Golden Triangle over the past decade (from 190 to 
30,000 ha) was indeed based on two pillars: growth and stability. 
Yet, containing a problem is not the same thing as solving it. Every year world markets 
are still supplied with about 1,000 tons of heroin (equivalent), another 1,000 tons of 
cocaine and untold volumes of marijuana, cannabis resin and synthetic drugs. So there 
is still much more to be done. 
2reducing demand from a health perspective
What about demand for drugs? Our statistics are as robust as they could possibly be, 
and I challenge our critics to provide better ones. They confirm that worldwide addiction 
to illicit drugs has stabilized since a few years. It is falling for some types of drugs, and/
or in some parts of the world, but rising in others. International controls have limited 
the number of people who take illicit drugs to a small fraction of the world’s adult 
population, much smaller than the number of people who use, and are killed by, other 
addictive substances like tobacco and alcohol. The roaring drug markets recorded at 
the beginning, as well as at the end of the 20th century have been tamed, but are certainly 
not bankrupt. 
UNGASS must have played a role in this. Most importantly, UNGASS has increased 
awareness that drug dependence is an illness. The United Nations Office on Drugs and 
Crime (UNODC) works with governments to place health at the centre of drug control, 
so as to put addicts in the hands of doctors rather than policemen. 
In the period ahead, a greater commitment is needed for prevention, treatment, and harm 
reduction—in an integrated, rather than mutually exclusive way. For this, UNODC has 
teamed up with the World Health Organization (WHO) to scale-up programmes around 
the world, and with UNAIDS to reduce the risk of HIV. 
a disturbing consequence of drug control
The UNGASS experience taught us that the drug problem has to be tackled at both 
ends: (a) more development assistance to reduce supply, and (b) more attention on 
health to lower demand. Further progress in these two areas would affect the intermedi-
ate stage: (c) it would curtail the drug trade. Let’s face it. While the drug regime has 
kept under control the otherwise enormous health threat posed by drugs, it has also had 
a dramatic unintended consequence: a criminal market of macroeconomic size. 
According to our estimates, the illicit global drug trade is valued at over US$300 billon 
a year. If it were a country, its gross national product (GNP) would be listed as 21st in 
the world—right after Sweden. 
The drug economy is more than just mafia cartels buying estates, businesses and aircrafts. 
They also buy officials, elections and parties. In a word, they buy power. Here is where 
the drug industry threatens security and development, in countries already stricken by 
poverty, unemployment and the HIV pandemic. This happens both where illicit crops 
are grown (in West Asia and the Andes), and where they are trafficked through (West 
Africa, Central America, the Caribbean and South-East Europe). 
what to do? avoid extreme positions
The crime crisis generates emotional responses. On one extreme, and perhaps out of 
frustration, ordinary people call for retribution—an eye for an eye, they say. This 
3misunderstands the nature of addiction, abdicates the state’s duty to protect its citizens, 
and violates human rights. Although drugs and crime kill, governments should not kill 
because of them. 
On the other extreme, a vocal pro-drug lobby argues that the damage done by drug 
control is greater than the harm caused by drugs. Legalize drugs, they say, to eliminate 
crime—namely, toss the proverbial baby out with the bath water! 
I suggest an approach that is not ideological, or emotional. Drugs are not harmful be-
cause they are controlled—they are controlled because they are harmful. The fact that 
certain unlawful transactions are hard to control doesn’t mean that they should be made 
legal. Should humanity accept paedophilia, human trafficking, or arms smuggling out 
of a naïve sense of market inevitability or intractability? Lifting the controls on drugs 
would reveal a state’s impotence to fight organized crime or protect the health of its 
citizens. 
It is incumbent on governments to achieve both objectives: to protect a public good 
(health), and contain one of the world’s foremost public bads (crime). It is rewarding 
to know that no country in this Commission disagrees with this view. Recent referenda 
in Europe are another bellwether, with the majority of public opinion stating loud and 
clear that: a policy change is needed against crime, not in favour of drugs. 
We should invest in the solid middle ground between: (a) criminalization of drug users 
and (b) legalization of its use, by framing our collective efforts against drugs less like 
a war, and more like an effort to cure a social disease. By way of metaphor, let us say 
that the world is afflicted with drug addiction (the disease), and the drug control system 
(the cure) has had a dramatic side effect (a huge criminal market). The blueprint I 
propose is detailed in our recent paper: Organized Crime and its Threat to Security. 
Here, I will only sketch the arguments. 
1. integrated, instead of disjointed, actions
First prong: measures to control drugs must be conceived as part of an integrated strategy. 
At present, drug control is a patchwork, with disjointed actions that address only some 
aspects of supply (eradicating crops, rather than poverty); displace the drug trade prob-
lem (from one country, or substance to another); or use a hammer instead of a chisel 
(criminalizing demand, rather than treating it). 
This compartmentalization doesn’t work. Drug markets (and their mafias) are integrated 
in their logistics, financing, marketing and bribery power. They do not stop at borders. 
Governments need to do the same. UNODC has been pro-active in this respect. We have 
brokered the Paris Pact as well as regional intelligence centres in Central Asia (CARICC) 
and the Gulf (GCCI) to stem the flow of Afghan heroin. We are promoting similar 
regional cooperation in the Balkans, West Africa, the Caribbean and Central America. 
Why not do the same in the Andean region and in South-East Asia? 
4Legal instruments to make these multi-tier arrangements work already exist. The United 
Nations Convention against organized crime, and especially its Protocol on Firearms, 
provides the platform for joint, rapid-impact action. Yet, this Protocol is not being 
implemented: look at the situation in Central America, where the flows of drugs to the 
North and of guns to the South undermine the security of nations. I urge all countries—
especially the arms producers—to ratify and implement the Firearms Protocol. 
2. community resistance
Now, the second prong. Drugs infect societies through open wounds. Similarly, crime 
cartels rule out-of-control regions (where there is supply), vulnerable areas (along trade 
routes), and derelict ghettos (where there is demand). Violence, instability, even terror-
ism are their direct cause, and consequence. Yet, like addiction, crime can be prevented 
and cured. The challenge is to reintegrate marginalized segments of society and draw 
them into, rather than push them out, of the law. 
Socio-economic measures, in addition to law enforcement, have proven effective at the 
beginning of the drug cycle (with development assistance offered to farmers) as well 
as at the end of the cycle (with health measures offered to addicts). Urban populations, 
caught in the midst of drug wars deserve the same help. 
Indeed, the largest share of the world’s drug trade and abuse can be traced to a few 
blocks, in a few neighbourhoods of a few big cities. The key to regaining control of 
these areas is for law enforcement, combined with social reintegration, to create viable 
alternatives for young people who are lost to addiction, or who have become urban child 
soldiers of crime syndicates. In a rapidly urbanizing world, drug control will be won, 
or lost, in the cities.
3. use existing legal instruments
The drug trade not only infects people: it also corrupts governments, together with 
business and finance. Nations need to improve governance so as to bolster resistance 
to drug cartels armed with war-chests worth billions of dollars. This leads me to the 
third prong: strengthening resistance mechanisms among nations by using existing 
instruments: the United Nations Conventions against crime and corruption. 
These instruments were designed to deal with the world mafias that traffic drugs, arms, 
and people. Yet, many governments are not taking them seriously. While ghettos burn, 
West Africa is under attack, drug cartels threaten Central America, and drug money 
penetrates bankrupt financial institutions, there are large gaps in the implementation of 
the Palermo and the Merida Conventions. Their rules of engagement are not yet agreed 
upon, years after their entry into force. As a result, a number of countries now face a 
crime situation largely caused by their own choice. This is bad enough. Worse is the 
fact that, quite often, vulnerable neighbours pay an even greater price. 
5Beyond containment
Ladies and gentlemen, the nations gathered in this historic session of the Commission 
on Narcotic Drugs (CND) unanimously support the United Nations treaties against 
drugs. The Political Declaration confirms this. Yet the drug conventions are under attack 
due to the emergence of drug cartels powerful enough to affect politics and business—
and to cause a panic reaction in public opinion. The cartels undermine security and 
development, causing some people to make a dangerous wager in favour of legalization. 
This malaise is not the fault of the founding fathers of drug control. It is an inescapable 
result of inadequate implementation of existing crime control agreements, and the 
unwillingness to examine stronger measures against money-laundering and cyber-crime. 
History will judge us severely unless we protect more effectively health, security and 
development.
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Political Declaration
 One decade after the commitments made at the twentieth special session of the 
General Assembly1 to address the world drug problem,2 notwithstanding the ever- 
increasing efforts and progress made by States, relevant international organizations and 
civil society, the drug problem continues to pose a serious threat to the health, safety 
and well-being of all humanity, in particular youth, our most precious asset. Furthermore, 
the world drug problem undermines sustainable development, political stability and 
democratic institutions, including efforts to eradicate poverty, and threatens national 
security and the rule of law. Drug trafficking and abuse pose a major threat to the health, 
dignity and hopes of millions of people and their families and lead to the loss of human 
lives. We are determined to tackle the world drug problem and to actively promote a 
society free of drug abuse in order to ensure that all people can live in health, dignity 
and peace, with security and prosperity; therefore: 
 We, the States Members of the United Nations,
 Gravely concerned about the growing threat posed by the world drug problem, 
having assembled, in a spirit of trust and cooperation, at the high-level segment of the 
fifty-second session of the Commission on Narcotic Drugs to decide on future priorities 
and urgent action to counter the world drug problem beyond 2009, and mindful of the 
important lessons learned from the implementation of the Political Declaration, action 
plans and guidelines adopted by the General Assembly at its twentieth special session 
with the aim of achieving measurable results,
 Fully aware that the world drug problem remains a common and shared respon-
sibility that requires effective and increased international cooperation and demands an 
integrated, multidisciplinary, mutually reinforcing and balanced approach to supply and 
demand reduction strategies,
 1
 See General Assembly resolutions S-20/2, S-20/3 and S-20/4 A to E.
 2
 The illicit cultivation, production, manufacture, sale, demand, trafficking and distribution of 
narcotic drugs and psychotropic substances, including amphetamine-type stimulants, the diversion of 
precursors and related criminal activities.
81. Reaffirm our unwavering commitment to ensure that all aspects of demand reduc-
tion, supply reduction and international cooperation are addressed in full conformity 
with the purposes and the principles of the Charter of the United Nations, international 
law and the Universal Declaration of Human Rights3 and, in particular, with full respect 
for the sovereignty and territorial integrity of States, the principle of non-intervention 
in the internal affairs of States, all human rights, fundamental freedoms, the inherent 
dignity of all individuals and the principles of equal rights and mutual respect among 
States;
2. Reaffirm also that the ultimate goal of both demand and supply reduction strategies 
and sustainable development strategies is to minimize and eventually eliminate the 
availability and use of illicit drugs and psychotropic substances in order to ensure the 
health and welfare of humankind and encourage the exchange of best practices in de-
mand and supply reduction, and emphasize that each strategy is ineffective in the absence 
of the other;
3. Assert that the world drug problem is most effectively addressed in a multilateral 
setting and that the three international drug control conventions4 and other relevant 
international instruments remain the cornerstone of the international drug control system, 
and urge all Member States that have not yet done so to consider taking measures to 
ratify or accede to those instruments;
4. Support the traditional and established supplier countries in maintaining a balance 
between the licit supply of and demand for opioids and opiate raw materials used for 
medical and scientific purposes;
5. Reaffirm the Political Declaration adopted by the General Assembly at its twentieth 
special session,5 the Declaration on the Guiding Principles of Drug Demand Reduction,6 
the Action Plan on International Cooperation on the Eradication of Illicit Drug Crops 
and on Alternative Development,7 the Action Plan for the Implementation of the 
Declaration on the Guiding Principles of Drug Demand Reduction8 and the Joint 
Ministerial Statement adopted during the ministerial segment of the forty-sixth session 
of the Commission on Narcotic Drugs;9
3
 General Assembly resolution 217 A (III).
4
 The Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol (United 
Nations, Treaty Series, vol. 976, No. 14152), the Convention on Psychotropic Substances of 1971 (ibid., 
vol. 1019, No. 14956) and the United Nations Convention against Illicit Traffic in Narcotic Drugs and 
Psychotropic Substances of 1988 (ibid., vol. 1582, No. 27627).
5
 General Assembly resolution S-20/2, annex.
6
 General Assembly resolution S-20/3, annex.
7
 General Assembly resolution S-20/4 E.
8
 General Assembly resolution 54/132, annex.
9
 A/58/124, sect. II.A.
9 6. Recall also the United Nations Millennium Declaration,10 the provisions of the 
2005 World Summit Outcome11 addressing the world drug problem, the Political 
Declaration on HIV/AIDS12 and other relevant United Nations resolutions, including 
General Assembly resolution 63/197 of 18 December 2008 and those on regional and 
international cooperation to prevent the diversion and smuggling of precursors;
 7. Note the commemoration, in Shanghai, China, on 26 and 27 February 2009, of 
the centennial of the convening of the International Opium Commission;
 8. Express deep concern at the high price paid by society and by individuals and 
their families in the fight against the world drug problem, and pay special tribute to the 
law enforcement and judicial personnel who have sacrificed their lives and to the health-
care and civil society personnel who have dedicated themselves to addressing this 
scourge;
 9. Acknowledge the important contribution made by women in curbing the world 
drug problem, commit ourselves to ensuring that drug control policies, measures and 
interventions take into account the specific needs and circumstances that women face 
with regard to drug problems, and decide to undertake effective measures to ensure that 
women, as well as men, have access to, and benefit equally and without discrimination 
from, drug control policies and strategies by involving them actively in all stages of 
programme and policy development and implementation;
10. Welcome the important role played by civil society, in particular non-governmental 
organizations, in addressing the world drug problem, and note with appreciation their 
important contribution to the review process, also noting that representatives of affected 
populations and civil society entities, where appropriate, should be enabled to play a 
participatory role in the formulation and implementation of drug demand and supply 
reduction policy;
11. Welcome also the reports of the Executive Director of the United Nations Office 
on Drugs and Crime on the world drug problem, the annual World Drug Report and the 
annual report of the International Narcotics Control Board and, on the basis of those 
reports, recognize that some progress has been made, through positive achievements, 
at the local, regional and international levels in implementing the Political Declaration 
adopted by the General Assembly at its twentieth special session but also recognize that 
there are still considerable challenges, as well as emerging challenges, to efforts to 
sustainably reduce, or at least effectively contain, illicit drug production, trafficking and 
consumption;
10
 See General Assembly resolution 55/2.
11
 See General Assembly resolution 60/1.
12
 General Assembly resolution 60/262, annex.
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12. Acknowledge the continuing efforts made and progress achieved in countering the 
world drug problem, note with great concern the unprecedented surge in illicit opium 
production and trafficking, the continuing illicit cocaine manufacture and trafficking, 
the increasing illicit cannabis production and trafficking and the increasing diversion 
of precursors, as well as the related distribution and use of illicit drugs, and stress the 
need to strengthen and intensify joint efforts at the national, regional and international 
levels to tackle those global challenges in a more comprehensive manner, in accordance 
with the principle of a common and shared responsibility, including by means of en-
hanced and better coordinated technical and financial assistance;
13. Agree that amphetamine-type stimulants and psychotropic substances continue 
to pose a serious and constantly evolving challenge to international drug control efforts, 
which threatens the security, health and welfare of the population, especially youth, and 
requires a focused and comprehensive national, regional and global response, based on 
scientific evidence and experience, in an international and multisectoral setting;
14. Decide to continue to raise public awareness of the risks and the threats posed to 
all societies by the different aspects of the world drug problem;
15. Take account of the need for indicators and instruments for the collection and 
analysis of accurate, reliable and comparable data on all relevant aspects of the world 
drug problem and, where appropriate, the enhancement or development of new indica-
tors and instruments, and recommend that the Commission on Narcotic Drugs take 
further measures to address that issue;
16. Reaffirm the principal role of the Commission on Narcotic Drugs and its subsidi-
ary bodies, together with the International Narcotics Control Board, as the United 
Nations organs with prime responsibility for drug control matters, and decide to promote 
and facilitate the effective implementation of and follow-up to the present Political 
Declaration and its Plan of Action;
17. Reaffirm also our support and appreciation for the efforts of the United Nations, 
including those of the United Nations Office on Drugs and Crime as the leading entity 
in the United Nations system for countering the world drug problem, reiterate our inten-
tion to continue to improve the governance and financial situation of the Office, stressing 
the need for adequate and stable financial resources to enable the Office to fulfil its 
mandates effectively, and request the Office to continue its efforts to carry out all its 
mandates under the international drug control conventions, as well as other relevant 
international instruments, and to continue to cooperate with relevant regional and in-
ternational institutions and Governments by providing, inter alia, technical assistance 
to Member States that request it;
18. Reaffirm further the leading role of the International Narcotics Control Board, as 
an independent treaty-based body, in monitoring the implementation of the international 
drug control conventions, in accordance with its mandate, including the control of 
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substances frequently used in the illicit manufacture of narcotic drugs and psychotropic 
substances, welcome the annual reports of the Board and support the Board in imple-
menting all its mandates under those conventions;
19. Call for continued cooperation between Member States, the International Narcotics 
Control Board and the World Health Organization to ensure the adequate availability 
of narcotic drugs and psychotropic substances under international control, including 
opiates, for medical and scientific purposes, while concurrently preventing their 
diversion into illicit channels, pursuant to the international drug control conventions;
20. Note with great concern the adverse consequences of drug abuse for individuals 
and society as a whole, reaffirm our commitment to tackle those problems in the context 
of comprehensive, complementary and multisectoral drug demand reduction strategies, 
in particular such strategies targeting youth, also note with great concern the alarming 
rise in the incidence of HIV/AIDS and other blood-borne diseases among injecting drug 
users, reaffirm our commitment to work towards the goal of universal access to com-
prehensive prevention programmes and treatment, care and related support services, in 
full compliance with the international drug control conventions and in accordance with 
national legislation, taking into account all relevant General Assembly resolutions and, 
when applicable, the WHO, UNODC, UNAIDS Technical Guide,13 and request the United 
Nations Office on Drugs and Crime to carry out its mandate in this area in close coop-
eration with relevant organizations and programmes in the United Nations system, such 
as the World Health Organization, the United Nations Development Programme and 
the Joint United Nations Programme on HIV/AIDS;
21. Reiterate our commitment to promote, develop, review or strengthen effective, 
comprehensive, integrated drug demand reduction programmes, based on scientific 
evidence and covering a range of measures, including primary prevention, early inter-
vention, treatment, care, rehabilitation, social reintegration and related support services, 
aimed at promoting health and social well-being among individuals, families and com-
munities and reducing the adverse consequences of drug abuse for individuals and 
society as a whole, taking into account the particular challenges posed by high-risk drug 
users, in full compliance with the three international drug control conventions and in 
accordance with national legislation, and commit ourselves to investing increased re-
sources in ensuring access to those interventions on a non-discriminatory basis, including 
in detention facilities, bearing in mind that those interventions should also consider 
vulnerabilities that undermine human development, such as poverty and social 
marginalization;
22. Reaffirm, consistent with the objective of promoting a society free of drug abuse, 
our determination, within the framework of national, regional and international 
13
 WHO, UNODC, UNAIDS Technical Guide for Countries to Set Targets for Universal Access to 
HIV Prevention, Treatment and Care for Injecting Drug Users (World Health Organization, Geneva, 
2009).
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strategies, to counter the world drug problem and to take effective measures to emphasize 
and facilitate healthy, productive and fulfilling alternatives to the illicit consumption of 
drugs, which must not become accepted as a way of life;
23. Reaffirm also our commitment to invest in and work with youth in a range of 
settings, including in families, schools, workplaces and communities, by raising public 
awareness and providing youth with information, skills and opportunities to choose 
healthy lifestyles, taking into account the World Programme of Action for Youth to the 
Year 2000 and Beyond, and working in coordination with the United Nations Programme 
on Youth of the Department of Economic and Social Affairs of the Secretariat;
24. Recognize that:
 (a) Sustainable crop control strategies targeting the illicit cultivation of crops 
used for the production of narcotic drugs and psychotropic substances require inter-
national cooperation based on the principle of shared responsibility and an integrated 
and balanced approach, taking into account the rule of law and, where appropriate, 
security concerns, with full respect for the sovereignty and territorial integrity of States, 
the principle of non-intervention in the internal affairs of States and all human rights 
and fundamental freedoms;
 (b) Such crop control strategies include, inter alia:
(i)   Alternative development and, where appropriate, preventive alternative 
development programmes;
(ii)  Eradication;
(iii) Law enforcement measures;
 (c) Such crop control strategies should be in full conformity with article 14 of 
the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic 
Substances of 1988,14 appropriately coordinated and phased in accordance with national 
policies in order to achieve the sustainable eradication of illicit crops, noting furthermore 
the need for Member States to undertake to increase long-term investment in such 
strategies, coordinated with other development measures, in order to contribute to the 
sustainability of social and economic development and poverty eradication in affected 
rural areas, taking due account of the traditional licit uses of crops where there is 
historical evidence of such use and giving due consideration to the protection of the 
environment;
25. Reiterate our commitment to promote and implement balanced policies and strate-
gies on precursor control with a view to preventing the diversion of precursors used in 
14
 United Nations, Treaty Series, vol. 1582, No. 27627.
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the illicit manufacture of drugs while ensuring that the legitimate trade in and use of 
those precursors are not adversely affected;
26. Emphasize that continued and persistent national, regional and international efforts 
based on improved understanding of the problem through the examination of scientific 
evidence and the sharing of experiences, forensic data and information are essential to 
preventing the diversion of precursors and other substances under international control 
that are used in the illicit production and manufacturing of narcotic drugs and psycho-
tropic substances, including amphetamine-type stimulants;
27. Express deep concern at the growing violence resulting from activities of criminal 
organizations involved in drug trafficking, and call for urgent measures to prevent those 
organizations from acquiring the means, in particular firearms and ammunition, to 
pursue their criminal activities;
28. Stress the urgent need to respond to the serious challenges posed by the increasing 
links between drug trafficking, corruption and other forms of organized crime, including 
trafficking in humans, trafficking in firearms, cybercrime and, in some cases, terrorism 
and money-laundering, including money-laundering in connection with the financing 
of terrorism, and to the significant challenges faced by law enforcement and judicial 
authorities in responding to the ever-changing means used by transnational criminal 
organizations to avoid detection and prosecution;
29. Recognize that, despite our past efforts, illicit crop cultivation and illicit drug 
production, manufacturing, distribution and trafficking have been increasingly consoli-
dated into a criminally organized industry generating enormous amounts of money, 
laundered through the financial and non-financial sectors and, therefore, commit our-
selves to strengthening the effective and comprehensive implementation of regimes for 
countering money-laundering and to improving international cooperation, including 
judicial cooperation, in order to prevent, detect and prosecute such crimes, dismantle 
criminal organizations and confiscate their illicit proceeds, and also recognize the need 
to train law enforcement and judicial personnel to utilize the tools available in the in-
ternational framework, as well as the need to encourage the development of such 
training;
30. Acknowledge the entry into force of the United Nations Convention against 
Transnational Organized Crime and the Protocols thereto15 and the United Nations 
Convention against Corruption,16 recognize that those conventions and other relevant 
international instruments constitute valuable tools for confronting the world drug 
problem, and urge Member States that have not yet done so to consider taking measures 
to ratify or accede to those instruments;
15
 United Nations, Treaty Series, vols. 2225, 2237, 2241 and 2326, No. 39574.
16
 Ibid., vol. 2349, No. 42146.
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31. Acknowledge also the importance of promoting, in order to enhance the effective-
ness of drug control measures, an integrated approach in drug policies, including ad-
dressing comprehensively the impact and consequences of such measures and strength-
ening their coordination and the assessment of their implementation;
32. Recognize that transit States are faced with multifaceted challenges resulting from 
illicit drugs being trafficked through their territory, and reaffirm our willingness to 
cooperate with those States and to assist them in progressively enhancing their capacity 
to counter the world drug problem;
33. Undertake to promote bilateral, regional and international cooperation, including 
through intelligence-sharing and cross-border cooperation, aimed at countering the 
world drug problem more effectively, in particular by encouraging and supporting such 
cooperation by those States most directly affected by illicit crop cultivation and the 
illicit production, manufacture, transit, trafficking, distribution and abuse of narcotic 
drugs and psychotropic substances;
34. Call for increased technical and financial assistance to Member States, in particular 
those most directly affected by the world drug problem, in order to ensure that they 
have the capacity to prevent and respond to that threat in all its forms and 
manifestations;
35. Commit ourselves to increasing cooperation at the regional and international levels, 
taking due account of situations where States are significantly affected by the illicit 
cultivation of crops used for the production of narcotic drugs and psychotropic sub-
stances and illicit trafficking in drugs and precursors, in order to counter the world drug 
problem and its impact on political stability, democratic institutions, security, the rule 
of law and sustainable development, including efforts to eradicate poverty;
36. Decide to establish 2019 as a target date for States to eliminate or reduce signifi-
cantly and measurably:
 (a) The illicit cultivation of opium poppy, coca bush and cannabis plant;
 (b) The illicit demand for narcotic drugs and psychotropic substances; and drug-
related health and social risks;
 (c) The illicit production, manufacture, marketing and distribution of, and traf-
ficking in, psychotropic substances, including synthetic drugs;
 (d) The diversion of and illicit trafficking in precursors;
 (e) Money-laundering related to illicit drugs;
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37. Recognize the need to increase investment in research and evaluation in order to 
properly implement and assess, based on evidence, effective policies and programmes 
for countering the world drug problem;
38. Adopt the Plan of Action, set out below, which constitutes an integral part of the 
present Political Declaration and complements the Political Declaration adopted by the 
General Assembly at its twentieth special session, the Action Plan on International 
Cooperation on the Eradication of Illicit Drug Crops and on Alternative Development 
and the Action Plan for the Implementation of the Declaration on the Guiding Principles 
of Drug Demand Reduction;
39. Commit ourselves to implementing effectively the present Political Declaration 
and its Plan of Action through resolute international cooperation, in collaboration with 
relevant regional and international organizations, with the full assistance of the inter-
national financial institutions and other relevant agencies and in cooperation with civil 
society, including non-governmental organizations, as well as the private and public 
sectors, and to reporting biennially to the Commission on Narcotic Drugs on the efforts 
to fully implement the Political Declaration and the Plan of Action, and also consider 
it necessary for the Commission to include on its agenda a separate item on follow-up 
to the Political Declaration and its Plan of Action;
40. Decide that the Commission on Narcotic Drugs at its fifty-seventh session, in 
2014, should conduct a high-level review of the implementation by Member States of 
the present Political Declaration and its Plan of Action, recommend that the Economic 
and Social Council devote a high-level segment to a theme related to the world drug 
problem, and also recommend that the General Assembly hold a special session to ad-
dress the world drug problem.
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Plan of action
Part i. Demand reduction and related measures
a.  reducing drug abuse and dependence through a comprehensive 
approach
1. enhancing international cooperation
Problem
1. The commitments made by Member States in 199817 to attain significant and meas-
urable results in the area of drug demand reduction have been attained only to a limited 
extent, owing largely to the lack of a balanced and comprehensive approach.
Action
2. Member States should:
 (a) Pursue a balanced and mutually reinforcing approach to supply and demand 
reduction, devoting more effort to the realization of demand reduction with a view to 
achieving proportionality of effort, resources and international cooperation in addressing 
drug abuse as a health and social issue, while upholding the law and its enforcement;
 (b) Scale up international assistance in addressing drug demand reduction in order 
to achieve a significant impact; to that end, long-term political and financial commit-
ments from Governments and the international community need to be ensured, including 
the strengthening of the United Nations Office on Drugs and Crime and other relevant 
international agencies;
 (c) Comprehensively support the reinforcement of the work that the United 
Nations Office on Drugs and Crime undertakes in drug demand reduction, in consulta-
tion with each other and with relevant United Nations and other intergovernmental 
organizations, in accordance with the Declaration on the Guiding Principles of Drug 
Demand Reduction,18 the Action Plan for the implementation of those principles19 and 
17
 See General Assembly resolutions S-20/2 and S-20/3.
18
 General Assembly resolution S-20/3, annex.
19
 General Assembly resolution 54/132, annex.
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the strategy of the United Nations Office on Drugs and Crime for the period 2008-
2011;20
 (d) Encourage, in cooperation with multilateral agencies and international and 
regional financial institutions, short-, medium- and long-term planning and continuous 
financial support for drug demand reduction programmes;
 (e) Encourage international and regional agencies working on drug demand re-
duction, in particular the United Nations Office on Drugs and Crime, the World Health 
Organization, the United Nations Development Programme, the Joint United Nations 
Programme on HIV/AIDS and the International Narcotics Control Board, to engage in 
dialogue in order to strengthen inter-agency cooperation for a more effective response 
to drug use and dependence, while respecting each organization’s role and mandate;
 (f) Also encourage dialogue regarding drug demand reduction with the 
International Narcotics Control Board, and other relevant United Nations bodies includ-
ing, as appropriate, human rights bodies, in accordance with the three international drug 
control conventions;21
 (g) Develop and implement, in cooperation with international and regional agen-
cies, a sound and long-term advocacy strategy, including harnessing the power of com-
munication media, aimed at reducing discrimination that may be associated with sub-
stance abuse, promoting the concept of drug dependence as a multifactorial health and 
social problem and raising awareness, where appropriate, of interventions based on 
scientific evidence that are both effective and cost-effective;
 (h) Promote the sharing of effective models for demand reduction that address 
the problem in a comprehensive manner.
2. comprehensive approach to drug demand reduction
Problem
3. Some countries have implemented effective drug demand reduction policies. 
However, drug demand reduction measures are often limited in the range of interven-
tions they offer. Measures are frequently planned and carried out in isolation and address 
only part of the health and socio-economic problems associated with drug use and 
dependence.
20
 Economic and Social Council resolution 2007/12, annex.
21
 The Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol (United 
Nations, Treaty Series, vol. 976, No. 14152), the Convention on Psychotropic Substances of 1971 (ibid., 
vol. 1019, No. 14956) and the United Nations Convention against Illicit Traffic in Narcotic Drugs and 
Psychotropic Substances of 1988 (ibid., vol. 1582, No. 27627).
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Action
4. Member States should:
 (a) Develop, review and strengthen, as appropriate, comprehensive and integrated 
drug demand reduction policies and programmes, providing a continuum of prevention 
and care in the health-care and social services, from primary prevention to early inter-
vention to treatment and to rehabilitation and social reintegration, and in related support 
services, aimed at promoting health and social well-being among individuals, families 
and communities and reducing the adverse consequences of drug abuse for individuals 
and society as a whole, taking into account the particular challenges posed by high-risk 
drug users, in full compliance with the three international drug control conventions and 
in accordance with national legislation;
 (b) Deliver comprehensive policies and programmes using a multi-agency ap-
proach, including health-care, social-care, criminal justice, employment and education 
agencies, non-governmental organizations and civil society, which should take full 
advantage of the activities of non-governmental and civil society organizations;
 (c) Develop, implement and disseminate demand reduction strategies as part of 
their respective comprehensive and balanced national drug control strategies, clearly 
describing objectives, interventions and funding, as well as defining roles, responsibili-
ties and mechanisms for different partners in all relevant sectors;
 (d) Undertake drug demand reduction efforts to address all forms of drug use, 
including misuse and dependence related to the consumption of two or more substances 
at the same time;
 (e) Ensure that drug demand reduction efforts address the vulnerabilities, such 
as poverty and marginalization, that undermine sustainable human development;
 (f) Deliver prevention programmes based on scientific evidence, both universal 
and targeted, in a range of settings (such as schools, families, the media, workplaces, 
communities, health and social services and prisons);
 (g) Consider integrating scientifically established mechanisms for the voluntary 
and early identification, diagnosis and intervention of drug disorders as part of routine 
health-care services;
 (h) Consider developing a comprehensive treatment system offering a wide range 
of integrated pharmacological (such as detoxification and opioid agonist and antagonist 
maintenance) and psychosocial (such as counselling, cognitive behavioural therapy and 
social support) interventions based on scientific evidence and focused on the process 
of rehabilitation, recovery and social reintegration;
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 (i) Strengthen their efforts aimed at reducing the adverse consequences of drug 
abuse for individuals and society as a whole, taking into consideration not only the 
prevention of related infectious diseases, such as HIV, hepatitis B and C and tuberculosis, 
but also all other health consequences, such as overdose, workplace and traffic accidents 
and somatic and psychiatric disorders, and social consequences, such as family problems, 
the effects of drug markets in communities and crime.
3.  human rights, dignity and fundamental freedoms in the context of drug demand 
reduction
Problem
5. There is an insufficient emphasis on human rights and dignity in the context of drug 
demand reduction efforts, in particular regarding access to the highest attainable standard 
of health services. There is also a need for an improved understanding of addiction and 
the growing recognition of it as a chronic but treatable multifactorial health disorder.
Action
6. Member States should:
 (a) Ensure that drug demand reduction measures respect human rights and the 
inherent dignity of all individuals and facilitate access for all drug users to prevention 
services and health-care and social services, with a view to social reintegration;
 (b) Promote meaningful livelihood activities and employment to instil a sense of 
purpose and self-esteem in individuals to steer them away from drugs;
 (c) Develop demand reduction programmes that focus on primary prevention, 
early intervention, treatment, care, rehabilitation and related support services, aimed at 
promoting health and social well-being among individuals, families and communities 
and reducing the adverse consequences of drug abuse for individuals and society as a 
whole, taking into account the particular challenges posed by high-risk drug users, in 
full compliance with the three international drug control conventions and in accordance 
with national legislation; and work within existing legal systems to develop mechanisms 
that link law enforcement processes to health-care systems, including, in the area of 
drug-related treatment, in accordance with national legislation.
4. measures based on scientific evidence
Problem
7. In many cases, drug use and dependence interventions aimed at prevention and care 
have been developed spontaneously by well-intentioned institutions responding to the 
urgency of a rapidly developing drug problem. Too often, however, those interventions 
were not based entirely on scientific evidence and a multidisciplinary approach. 
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Action
8. Member States should:
 (a) Invest adequate resources in measures based on scientific evidence, building 
on the significant scientific progress achieved in that area; 
 (b) Support and widely disseminate, in collaboration with the international com-
munity, further research to develop measures based on scientific evidence that are rel-
evant to different socio-cultural environments and social groups;
 (c) Encourage innovative measures and incorporate evaluation in order to respond 
to present and future challenges; and take into account the possibilities given by new 
media and technologies, including the Internet, with a view to developing the scientific 
evidence base. 
5. availability of and accessibility to drug demand reduction services
Problem
9. A range of barriers to specific drug demand reduction services makes it difficult 
for those in need to access those services.
Action
10. Member States should:
 (a) Ensure that access to drug treatment that is affordable, culturally appropriate 
and based on scientific evidence is available and that drug dependence care services are 
included in health-care systems, whether public or private, with the involvement of 
primary and, where appropriate, specialized health-care services, in accordance with 
national legislation;
 (b) Ensure, where appropriate, the sufficient availability of substances for 
medication-assisted therapy, including those within the scope of control under the 
international drug control conventions, as part of a comprehensive package of services 
for the treatment of drug dependence;
 (c) Continue to comply with the procedures established under the international 
drug control conventions and relevant resolutions of the Economic and Social Council 
relating to the submission to the International Narcotics Control Board of estimates of 
their requirements for narcotic drugs and assessments of requirements for psychotropic 
substances so as to facilitate the import of the required narcotic drugs and psychotropic 
substances and to enable the Board, in cooperation with Governments, to maintain a 
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balance between the demand for and the supply of those drugs and substances in order 
to ensure the relief of pain and suffering and the availability of medication-assisted 
therapy as part of a comprehensive package of services for the treatment of drug de-
pendence, while bearing in mind, in accordance with national legislation, the World 
Health Organization Model List of Essential Medicines.
6. mainstreaming community involvement and participation
Problem
11. In many cases, interventions tend to be supported through isolated and short term 
initiatives and are not mainstreamed in the regular provision by Governments of public 
health, education and social services. Moreover, they do not involve all stakeholders at 
the community level in the planning, delivery, monitoring and evaluation of drug demand 
reduction measures, and they do not take full advantage of the activities of non-govern-
mental organizations and civil society. 
Action
12. Member States should:
 (a) Ensure, to the extent possible, that measures are mainstreamed in the provi-
sion of public and private health, education and social services (such as family, housing 
and employment services);
 (b) Involve all stakeholders at the community level (including the target popula-
tions, their families, community members, employers and local organizations) in the 
planning, delivery, monitoring and evaluation of drug demand reduction measures;
 (c) Involve communication media in supporting ongoing drug prevention 
programmes through well-targeted campaigns;
 (d) Promote collaboration between governmental and non-governmental or-
ganizations and other members of civil society in the establishment of drug demand 
reduction measures at the local level.
7. targeting vulnerable groups and conditions
Problem
13. Drug demand reduction interventions too often target the general population at 
large with a single standard approach and do not provide specialized programmes tail-
ored to vulnerable groups with specific needs. Those groups include, among others, 
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children, adolescents, vulnerable youth, women, including pregnant women, people 
with medical and psychiatric co-morbidities, ethnic minorities and socially marginalized 
individuals. A person may belong to more than one of these groups and thus have mul-
tiple needs.
Action
14. Member States should:
 (a) Ensure that a broad range of drug demand reduction services, including 
those in the areas of prevention, treatment, rehabilitation and related support services, 
provide approaches that serve the needs of vulnerable groups and are differentiated on 
the basis of scientific evidence so that they respond best to the needs of those groups, 
taking into account gender considerations and cultural background;
 (b) Ensure that prevention programmes target and involve youth and children 
with a view to increasing their reach and effectiveness;
 (c) Provide specialized training for those who work with vulnerable groups, 
such as patients with psychiatric co-morbidities, minors and women, including pregnant 
women.
8. Drug use and dependence care in the criminal justice system
Problem
15. There are limited alternatives to prosecution and imprisonment for drug-using 
offenders, and treatment services within the criminal justice system are frequently in-
adequate. Moreover, issues such as corruption, overcrowding and access to drugs and 
their adverse effects, including the frequency of transmission of infectious diseases 
within prisons, need to be addressed. Finally, increased emphasis should be placed on 
the transition between incarceration and release, re-entry and social reintegration.
Action
16. Member States should:
 (a) Working within their legal frameworks and in compliance with applicable 
international law, consider allowing the full implementation of drug dependence treat-
ment and care options for offenders, in particular, when appropriate, providing treatment 
as an alternative to incarceration;
 (b) Take measures to address corruption, reduce overcrowding and prevent 
access to and use of illicit drugs within detention facilities;
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 (c) Implement comprehensive treatment programmes in detention facilities; 
commit themselves to offering a range of treatment, care and related support services 
to drug-dependent inmates, including those aimed at prevention of the transmission of 
related infectious diseases, pharmacological and psychosocial treatment and rehabilita-
tion; and further commit themselves to providing programmes aimed at preparation for 
release and prisoner support programmes for the transition between incarceration and 
release, re-entry and social reintegration;
 (d) Provide appropriate training so that criminal justice and/or prison staff carry 
out drug demand reduction measures that are based on scientific evidence and are ethical 
and so that their attitudes are respectful, non-judgemental and non-stigmatizing.
9. Quality standards and training of staff 
Problem
17. Inadequately trained personnel and a lack of certification and quality standards 
hinder the effective implementation of demand reduction measures based on scientific 
evidence.
Action 
18. Member States should:
 (a) Support the development and adoption of appropriate health-care standards, 
as well as ongoing training on drug demand reduction measures;
 (b) Ensure that services are staffed, to the extent possible and as appropriate, 
with multidisciplinary teams, including physicians/psychiatrists, nurses, psychologists, 
social workers, educators and other professionals;
 (c) Ensure, where appropriate, that the educational curricula for relevant service 
providers, including the curricula of universities, medical schools and other relevant 
professions, include training on the prevention of drug use and dependence and related 
care;
 (d) Provide training to planners and practitioners of governmental agencies, 
non-governmental organizations, the private sector and others in the community, on a 
permanent basis, on all aspects of demand reduction activities and strategic program-
ming by identifying local, national, subregional and regional human resources and using 
their experience in the design of programmes to guarantee their continuity and to create 
and strengthen local, regional, subregional and national training and technical resource 
networks and, with the possible assistance of regional and international organizations, 
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to facilitate the exchange of experiences and expertise by encouraging States to include 
demand reduction personnel from other States in training programmes that they have 
developed;
 (e) Support national, regional and international networks to provide training 
and develop and disseminate successful practices.
10. Data collection, monitoring and evaluation 
Problem
19. The lack of data, particularly on the rapidly changing nature and the extent of 
drug use, and the lack of systematic monitoring and evaluation by Governments of the 
coverage and quality of drug demand reduction measures are matters of great concern. 
Intensified international cooperation and support is necessary, including for improved 
and coordinated data collection, monitoring and evaluation of demand reduction pro-
grammes to inform demand reduction services and policy. 
Action
20. Member States should:
 (a) Increase their efforts in collecting data on the nature and extent of drug use 
and dependence, including the characteristics of the population in need, strengthening 
information and monitoring systems and employing methodologies and instruments 
based on scientific evidence;
 (b) Develop and improve methods of objective national assessment by 
Governments to understand in a systematic and holistic manner the negative impact of 
drug abuse on society, health and economies;
 (c) Ensure that drug demand reduction measures are based on scientifically 
sound assessments of the nature and extent of the drug problem, as well as the social 
and cultural characteristics of the population in need;
 (d) Ensure that drug demand reduction measures are based on drug use trends 
in the community and are revised periodically on the basis of new trends, feedback and 
monitoring and evaluation processes;
 (e) Ensure that drug use and dependence prevention and care interventions, as 
well as other demand reduction measures, include adequate record-keeping systems, 
while maintaining confidentiality, and that drug dependence care record-keeping systems 
are part of an active system for monitoring the nature and extent of the drug problem;
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 (f) Take an integrated and comprehensive approach to data collection and 
analysis to ensure that the information available in international, regional and national 
bodies is fully and legally utilized; and provide technical assistance to those countries 
where capacity is less developed;
 (g) Seek agreement on a set of relevant indicators covering key issues to allow 
for the comparable assessment of the effectiveness of demand reduction measures with 
a view to developing, adapting and validating simple, standardized United Nations 
data-collection and evaluation methods, concepts and tools;
 (h) Develop, in cooperation with the international community and in the light 
of lessons learned in the analysis of replies to the annual reports questionnaire and the 
biennial reports questionnaire, enhanced data-collection instruments to be considered 
and adopted by the Commission on Narcotic Drugs, allowing streamlined measurement 
of the quality, extent and coverage of drug demand reduction measures, ensuring that 
the tools used are appropriate for the different needs and reporting capacities of countries 
and are scientifically sound, making full use of existing information resources and, 
benefiting from, if appropriate, the experience of the existing regional monitoring sys-
tems, while minimizing the reporting burden.
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Part ii. supply reduction and related measures
B. reducing the illicit supply of drugs
1.  enhancing cooperation, coordination and law enforcement operations to reduce 
supply
Problem
21. While the majority of States have adopted and implemented supply reduction 
policies and made supply reduction an important priority, the commitment made by 
Member States in 1998 to attain significant and measurable results in the area of supply 
reduction has been attained only to a limited extent, owing, inter alia, to the lack of 
effective implementation of drug supply policies, the lack of appropriate national leg-
islative frameworks for international cooperation, inadequate information-sharing and 
monitoring and control mechanisms and the lack of coordinated law enforcement opera-
tions, as well as the insufficient and unstable allocation of resources.
Action
22. Member States should:
 (a) In order to reinforce the fight against narcotic drugs and psychotropic sub-
stances, ensure, in cooperation with multilateral agencies and international and regional 
financial institutions, the implementation of short-, medium- and long-term planning 
so as to ensure a sufficient and stable allocation of resources for drug supply reduction 
programmes;
 (b) Promote the exchange of best practices and successful experiences in the 
area of drug supply reduction;
 (c) Ensure that supply reduction measures are carried out in full conformity 
with the purposes and the principles of the Charter of the United Nations and interna-
tional law, the three international drug control conventions and, in particular, with full 
respect for the sovereignty and territorial integrity of States, the principle of non- 
intervention in the internal affairs of States and all human rights and fundamental 
freedoms;
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 (d) Continue to rely on the three international drug control conventions as the 
primary legal framework for tackling the world drug problem, taking into account the 
relevance of the United Nations Convention against Transnational Organized Crime 
and the Protocols thereto22 and the United Nations Convention against Corruption,23 
and supporting the pursuit of broader adherence to and implementation of those 
instruments;
 (e) Promote supply reduction measures that take due account of traditional licit 
uses, where there is historical evidence of such use, as well as environmental protection, 
in conformity with the United Nations Convention against Illicit Traffic in Narcotic 
Drugs and Psychotropic Substances of 1988;24
 (f) Promote and implement multilateral, regional, subregional and bilateral 
cooperation among judicial and law enforcement authorities to combat the involvement 
of criminal organizations in drug production and trafficking and related criminal 
activities;
 (g) Ensure that the international response to the drug problem beyond 2009 
continues to be pursued as a common and shared responsibility, requiring a balanced 
approach for purposes of international cooperation and the provision of technical 
assistance;
 (h) Ensure that international and regional agencies working on drug supply 
reduction engage in dialogue to strengthen inter-agency cooperation for a more effective 
response, while respecting each organization’s role and mandate;
 (i) Further develop and implement effective legislation and legislative 
frameworks for multilateral, regional, subregional and bilateral cooperation, including 
agreements on mutual legal assistance and extradition, and address appropriately issues 
regarding jurisdiction, expedite the processing of mutual legal assistance and extradition 
requests and, where possible, carry out joint investigations;
 (j) Maintain and expand, in collaboration with the international community, 
projects and programmes to foster bilateral and regional cooperation on specific supply 
reduction issues;
 (k) Consider reassessing the current data-collection strategies and instruments 
so as to facilitate the compilation of reliable, relevant, comparable and usable data on 
drug supply in order to ensure a strong and common understanding of the issue, and, 
in that regard, consider adjusting and standardizing international data collection 
efforts;
22
 United Nations, Treaty Series, vols. 2225, 2237, 2241 and 2326, No. 39574.
23
 Ibid., vol. 2349, No. 42146.
24
 Ibid., vol. 1582, No. 27627.
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 (l) Remain up to date on scientific studies, data and research on the medicinal 
and other legitimate uses of plants containing narcotic and psychotropic substances, 
taking into account the provisions of the three international drug control conventions;
 (m) Establish, through the Commission on Narcotic Drugs and in coordination 
with the Statistical Commission of the Economic and Social Council, clear and measur-
able indicators in the area of supply reduction in order to accurately assess the achieve-
ment of any goals and targets that might be set by the international community beyond 
2009;
 (n) Provide the United Nations entities having pertinent expertise with resources 
for the collection of data and the provision of technical and financial assistance to States 
with a view to enhancing their ability to address trafficking in narcotic drugs and psy-
chotropic substances; coordination with and among United Nations entities and various 
multilateral entities should be strengthened;
 (o) Take additional steps to present a coordinated and coherent response to 
trafficking in narcotic drugs and psychotropic substances by land, air and sea, in part-
nership with United Nations entities and international partners, so as to close jurisdic-
tional gaps in the investigation, interdiction and prosecution of traffickers;
 (p) Ensure that further encouragement and assistance are provided for the shar-
ing of information through official channels in a timely manner, the implementation of 
border control measures, the provision of equipment, the exchange of law enforcement 
officers, collaboration between the private and public sectors and the development of 
practical new methods for effectively monitoring drug trafficking activities;
 (q) Establish, when appropriate, multi-agency bodies to ensure that a compre-
hensive approach is being taken in tackling drug trafficking networks, while remaining 
aware that organized criminal groups engaged in drug trafficking are likely to be engaged 
in other forms of trafficking; the multi-agency bodies will help to ensure that agencies 
fighting other forms of organized crime share relevant information, intelligence, practices 
and resources with drug law enforcement agencies.
2. addressing new trafficking trends
Problem
23. As new trends in drug trafficking emerge, they may pose significant challenges 
to the ability of States to provide a vigorous and effective response. 
Action
 24. Member States should:
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 (a) Ensure that law enforcement agencies are able to adapt in order to adequately 
address the changing nature of the drug trafficking problem, particularly with regard to 
new technologies, routes and methods used by traffickers, thereby reducing the illicit 
supply of drugs;
 (b) Take into account possible linkages between trafficking in narcotic drugs 
and trafficking in psychotropic substances, the involvement of terrorist groups in some 
parts of the world, corruption and transnational organized crime, including trafficking 
in firearms and money-laundering, when developing and implementing supply reduction 
strategies;
 (c) Continue to give attention to the development of methods for gathering 
and using hard-to-reach intelligence25 and evidence, including judicially sanctioned 
evidence-gathering techniques such as electronic surveillance, structured informant 
programmes and controlled delivery;
 (d) Promote the exchange of intelligence among countries of origin, transit and 
destination to combat drug trafficking, while safeguarding the sources and the integrity 
of information; 
 (e) Monitor, in collaboration with the international community, the nature, use, 
extent and impact of cybertechnology on trafficking in narcotic drugs and psychotropic 
substances and give consideration to the development and implementation of legislation 
and training opportunities in order to respond effectively to the emerging problem;
 (f) Make efforts to ensure that appropriate procedural and substantive legisla-
tion is developed at the national level to deal with drug trafficking carried out in an 
electronic environment, including a framework for the effective regulation and oversight 
of online pharmacies operating or delivering pharmaceutical preparations containing 
internationally controlled narcotic drugs and/or psychotropic substances within their 
respective jurisdictions; 
 (g) Implement strategies to disrupt and dismantle major organizations involved 
in trafficking in narcotic drugs and psychotropic substances and to address emerging 
trends;
 (h) Provide assistance to transit States to combat trafficking in narcotic drugs 
and psychotropic substances more efficiently.
25
 Lawfully gathered information obtained through the use of structured programmes, such as reg-
istered informants, undercover officers, electronic surveillance for intercepting audio and/or video, con-
trolled delivery and other techniques acceptable to the judicial process.
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3. reducing violence related to drug trafficking 
Problem
25. In some cases, criminal organizations involved in drug trafficking are exposing 
civil society and law enforcement authorities to increasing levels of harm and violence, 
in particular because of their propensity to be heavily armed with illicitly manufactured 
and trafficked firearms and to engage in violence to protect themselves and their illicitly 
trafficked drugs. The international community must take steps to not only reduce the 
illicit supply of drugs but also reduce the violence that accompanies drug trafficking. 
Action
26. Member States should:
 (a) Consider ratifying or acceding to and, where possible and appropriate, 
strengthening the implementation of, the Protocol against the Illicit Manufacturing of 
and Trafficking in Firearms, Their Parts and Components and Ammunition, supplement-
ing the United Nations Convention against Transnational Organized Crime26 in order 
to reduce the illicit manufacturing of and trafficking in firearms as a means of reducing 
the violence associated with drug trafficking;
 (b) Implement preventive and enforcement measures to combat all forms of 
criminal activity that may be linked to trafficking in narcotic drugs and psychotropic 
substances, such as money-laundering, trafficking in persons, the smuggling of migrants 
and, where appropriate, the financing of terrorism, including the detection of cash and 
other negotiable items that cross international borders;
 (c) Provide adequate and targeted training to law enforcement, customs and 
border control authorities in combating trafficking in narcotic drugs and psychotropic 
substances and, where appropriate, illicit trafficking in firearms, increase, in the case 
of States with relevant experience, bilateral and multilateral cooperation, including 
through programmes administered by the United Nations Office on Drugs and Crime 
and other international partners, United Nations agencies or regional mechanisms, 
focused on capacity-building and training, and exchange experiences and best practices 
so as to increase the ability of all States to more effectively fight trafficking in narcotic 
drugs and psychotropic substances and, where appropriate, illicit trafficking in 
firearms;
 (d) Increase information-sharing among law enforcement authorities and judi-
cial cooperation in order to identify and investigate possible links between the criminal 
organizations involved in trafficking in narcotic drugs and psychotropic substances and 
26
 United Nations, Treaty Series, vol. 2326, No. 39574.
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other criminal activities, including, in particular, the illicit manufacturing of and 
trafficking in firearms.
4. addressing supply and demand reduction together
Problem
27. While drug trafficking is a multifaceted issue that can be effectively tackled only 
by reducing both supply and demand, this interlinkage is often not taken into account. 
Supply reduction must involve the application of a balanced approach to reduce demand 
under the principle of shared responsibility, just as demand reduction must involve the 
application of a balanced approach to reduce supply under the principle of shared 
responsibility.
Action
28. Member States should:
 (a) Employ in their national drug control strategies a multidisciplinary approach 
and include different Government agencies having an interest in combating drug traf-
ficking, including in the areas of health, law enforcement and education, to ensure that 
all of the factors relevant to reducing supply are taken into account when developing 
and implementing supply reduction strategies;
 (b) Address the need for a comprehensive, multisectoral and balanced approach 
involving demand reduction and supply reduction, each reinforcing the other, together 
with the appropriate application of the principle of shared responsibility, while stressing 
the need for services responsible for prevention, including law enforcement agencies, 
and ensuring that those measures are mainstreamed in publicly and privately provided 
health, education, rural development, agriculture and social services.
5. strengthening of anti-corruption measures and provision of technical assistance 
and capacity-building
Problem
29. Organized criminal groups, in order to facilitate and protect their illicit trade in 
drugs, often attempt to influence public officials, including law enforcement authorities. 
Efforts to reduce supply must be complemented by anti-corruption measures and must 
employ a comprehensive approach that involves the cooperation of both government 
and civil society. In this context, several developing countries, especially those on major 
drug trafficking routes, require technical assistance to further strengthen their law en-
forcement agencies.
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Action
30. Member States should:
 (a) Consider ratifying or acceding to and strengthening their implementation 
of the Convention against Corruption, the 1988 Convention and the United Nations 
Convention against Transnational Organized Crime;27
 (b) Ensure that proactive strategies are pursued by law enforcement agencies 
to prevent corruption, such as participating in multilateral and bilateral anti corruption 
technical assistance programmes, preparing anti-corruption action plans and instituting 
integrity programmes for law enforcement officials; 
 (c) Further develop and improve domestic and international training and 
awareness-raising efforts for law enforcement and judicial capacity-building, while 
ensuring the coordination of international training and awareness-raising efforts in order 
to avoid duplication; 
 (d) Further develop and support the use of controlled delivery, consistent with 
the 1988 Convention, and other special investigative techniques, both nationally and 
internationally, consistent with their national legislation;
 (e) Enhance efforts to acquire knowledge of the modus operandi of drug traf-
fickers, including through regional and international mapping exercises;
 (f) Harness the resources of existing international police structures and institu-
tions to address the issue of trafficking in narcotic drugs and psychotropic substances 
in a coordinated manner and to ensure a greater degree of efficiency and efficacy; 
 (g) Provide adequate resources and equipment to border management agencies 
and provide technical assistance to requesting States in this regard;
 (h) Strengthen and integrate law enforcement capabilities to enable them to 
better investigate organized criminal groups engaged in trafficking in narcotic drugs 
and psychotropic substances;
 (i) Encourage the development and introduction of sustainable and compre-
hensive programmes in judicial and law enforcement institutions, which should address 
conditions of service, remuneration, training and awareness-raising so as to attract and 
retain the best personnel; 
27
 Ibid., vol. 2225, No. 39574.
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 (j) Ensure that commercial port operations are supported by drug law enforce-
ment authorities with adequate resources, equipment, training and legal powers to ef-
fectively screen, evaluate and examine commercial freight and sea bound containers 
and also ensure that relevant international agencies provide technical assistance to re-
questing States in this regard.
c. control of precursors and of amphetamine-type stimulants
1. improving understanding of the phenomenon of amphetamine-type stimulants
Problem
31. Because of the absence of a systematic global mechanism for monitoring the illicit 
manufacture, prevalence patterns and abuse of and trafficking in amphetamine-type 
stimulants28 and of a global approach to controlling illicit synthetic drugs and the manu-
facturing and diversion of and trafficking in precursor chemicals, it is still not possible 
to fully understand the illicit market for synthetic drugs and its characteristics. Many 
Member States have not yet implemented measures to detect and monitor this part of 
the illicit drug market and evaluate the responses to it, have limited data on which to 
base the planning and programming of actions and consequently have limitations with 
respect to scientific evidence in formulating programmes to tackle it more effectively. 
In addition, some countries lack the financial and human resources and the know-how 
to tackle this problem.
Action
32. Member States should:
 (a) Take measures to advance the monitoring of illicit synthetic drugs, where 
it does not already exist, linking existing activities related to amphetamine-type stimu-
lants around the world, and take measures to further the development of monitoring 
capacity, including for the early identification of emerging trends and to generate preva-
lence data on amphetamine-type stimulants;
 (b) Emphasize the critical importance of forensic and scientific laboratory and 
treatment centre data and qualitative information in understanding the problem of illicit 
synthetic drugs and the range of products available on the illicit market and systemati-
cally integrate such data and information into their monitoring and investigation 
activities;
28
  The Synthetics Monitoring: Analysis, Report and Trends (SMART) programme, set up in 
September 2008, is already in the early stage of development in some regions.
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 (c) Promote consultative mechanisms between the International Narcotics 
Control Board, the United Nations Office on Drugs and Crime and other relevant inter-
national and regional bodies in order to enhance the quality and consistency of reported 
data on amphetamine-type stimulants and other synthetic drugs and their precursors;
 (d) Take further measures to advance international information-sharing (i.e. 
the electronic linking, through the Internet, of national, regional and international docu-
mentation centres) to ensure the global dissemination of accurate and timely information, 
in a standardized manner, on various aspects of the problem of amphetamine-type 
stimulants (including interdictions, prevalence rates and analysis of policies, legislation 
and operational responses to inform best practices);
 (e) Continue to complement monitoring activities by conducting more system-
atic research into the problem of amphetamine-type stimulants, including more detailed 
examinations of the complex interplay between the demand for and the supply of am-
phetamine-type stimulants in different contexts, and by conducting and making available 
the results of studies to establish the prevalence and identify the risks of the use of 
amphetamine-type stimulants.
2. targeting the clandestine manufacture of amphetamine-type stimulants
Problem
33. Synthetic drugs pose a special problem, as they can be illicitly manufactured in 
a variety of forms using precursor chemicals, many of which can be easily substituted. 
In addition, the clandestine and potentially mobile nature of their manufacture requires 
a global approach in order to understand and prevent the diversion of synthetic drugs 
and their precursors into illicit channels in all manufacturing, transit and consumer 
countries.
Action
34. Member States should:
 (a) Develop or strengthen their national capacity for the safe investigation and 
handling of seized clandestine laboratories for amphetamine-type stimulants, chemical 
warehouses and precursor chemicals, while building on existing forensic laboratory 
resources;
 (b) Identify best practices for systematically conducting inventories of clan-
destine laboratory sites, including the laboratory equipment, clandestine manufacturing 
methods, starting materials, chemicals and reagents used, and improve the exchange of 
such information in a timely and standardized way;
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 (c) Monitor on a voluntary basis, to the extent possible, the sale of laboratory 
and other equipment, such as tablet presses, in compliance with article 13 of the 1988 
Convention.
3. Preventing illegal sale and diversion
Problem
35. The diversion of pharmaceutical preparations, the manufacture and marketing of 
mixtures of amphetamine-type stimulants and other synthetic drugs, the use of non-
controlled chemicals and/or substitute chemicals as new precursors for the illicit syn-
thesis of drugs and the use and distribution of pharmaceutical products with a view to 
circumventing appropriate controls on manufacture are crucial challenges for Member 
States in tackling the problem of amphetamine-type stimulants.
Action
36. Member States should:
 (a) Address through concerted action the illegal sale of preparations containing 
amphetamine-type stimulants via the Internet and the misuse of postal and courier 
services for smuggling such preparations;
 (b) Take measures to advance cooperation in the detection and investigation of 
diversion cases and for the sharing of experiences and information among competent 
national bodies on specific types of diversion;
 (c) Strengthen controls, including through the Pre-Export Notification Online 
system, where required, for the import and export of preparations containing precursor 
chemicals, such as ephedrine and pseudoephedrine, which could be used in the manu-
facture of amphetamine-type stimulants;
 (d) Advance the systematic collection of data on the abuse of amphetamine-type 
stimulants and the diversion of precursors and preparations containing amphetamine-
type stimulants and use the data to take appropriate countermeasures;
 (e) Provide technical assistance, as appropriate, for the development and im-
plementation of adequate controls over the manufacture, sale, diversion and abuse of 
amphetamine-type stimulants, including legislative, administrative and operational 
responses, particularly in regions where there is an absence of such controls.
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4. raising awareness and reducing demand
Problem
37. Despite the potentially serious risks associated with the use of amphetamine-type 
stimulants and other synthetic drugs, they are nevertheless incorrectly believed to be 
compatible with healthy lifestyles. It is therefore important to raise greater awareness 
about the potential risks associated with the use of these substances.
Action
38. Member States should:
 (a) Raise awareness of amphetamine-type stimulants and their precursors with 
law enforcement, health and regulatory authorities and educate vulnerable population 
groups as to the dangers associated with the use of amphetamine-type stimulants;
 (b) Encourage access to comprehensive services, such as treatment, rehabilita-
tion and social reintegration, to address substance abuse, including the abuse of am-
phetamine-type stimulants, under the supervision of health-care and other appropriate 
providers, for individuals with problems related to amphetamine-type stimulants, in 
view of the widespread availability and illicit use of amphetamine-type stimulants by 
a wide range of population groups;
 (c) Develop prevention and treatment programmes tailored to the specific 
characteristics of the phenomenon of amphetamine-type stimulants as key elements in 
any relevant strategy to reduce demand and minimize health risks.
5. emerging issues in precursor control
Problem
39. While legislative and regulatory controls have prevented the diversion of precursor29 
chemicals into illicit channels, such chemicals still reach clandestine drug laboratories. 
Precursor chemicals are often diverted from domestic distribution channels in the 
countries that manufactured or imported them and are smuggled across borders. 
29
 The term “precursor” is used to indicate any of the substances listed in Table I or Table II of 
the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 
1988, except where the context requires a different expression. Such substances are often described as 
precursors or essential chemicals, depending on their principal chemical properties. The plenipotentiary 
conference that adopted the 1988 Convention did not use any one term to describe such substances. 
Instead, the expression “substances frequently used in the illicit manufacture of narcotic drugs or psy-
chotropic substances” was introduced in the 1988 Convention. It has become common practice, however, 
to refer to all such substances simply as “precursors”; although that term is not technically correct, it is 
used in this text for the sake of brevity.
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Countries not previously targeted by traffickers are now used as areas of diversion. 
Non-controlled precursor chemicals and/or substitute chemicals, as well as pharmaceuti-
cal preparations containing precursors, have been used in the illicit synthesis of drugs. 
In addition, scientific and forensic support in the identification and safe disposal of 
precursors is still inadequate in many countries.
40. The absence of a global mechanism for the exchange of laboratory information 
and law enforcement findings between drug control agencies, customs officials and 
police remains a global challenge in the control of amphetamine-type stimulants and 
their precursors.
Action
41. Member States should:
 (a) Further strengthen mechanisms, as appropriate, for the timely identification, 
collection and exchange of information on non-scheduled substances, including deriva-
tives specifically designed to circumvent existing controls, especially by making use of 
the updated international special surveillance list of non-scheduled substances;
 (b) Further strengthen legislation, as appropriate, on the control of precursors 
and the criminalization of their diversion;
 (c) Ensure that measures to control precursors and amphetamine-type stimulants 
are carried out in full conformity with the purposes and the principles of the Charter of 
the United Nations and international law, the international drug control conventions 
and, in particular, with full respect for the sovereignty and territorial integrity of States, 
the principle of non-intervention in the internal affairs of States and all human rights 
and fundamental freedoms;
 (d) Conduct further research on precursors to understand emerging trends, such 
as the use of substitute chemicals and the splitting of the production process, including 
proactive studies on the potential use of such substances, and share the results of such 
research;
 (e) Further advance working relations with the relevant industries to promote 
the formulation of a universal code of conduct for industry and appropriate national and 
international legislation on the supply of and trafficking in precursors, including those 
not yet under international control, and invite the International Narcotics Control Board 
to provide guidelines on how to establish cooperation between competent national 
authorities and operators;
 (f) Focus greater attention on the use of non-scheduled substances and substitute 
chemicals for the manufacture of traditional precursors used in the manufacture of 
heroin and cocaine;
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 (g) Cope with the multiple challenges faced by the drug control agencies of 
developing countries, especially in view of the emergence of new synthetic drugs and 
amphetamine-type stimulants in those markets, through capacity-building and technical 
assistance involving, inter alia, the provision of advanced detection equipment, scanners, 
testing kits, forensic laboratories and training;
 (h) Ensure that international and regional agencies working on the control of 
precursors and amphetamine-type stimulants engage in dialogue to strengthen inter 
agency cooperation for a more effective response while respecting each agency’s role 
and mandate;
 (i) Support efforts by the United Nations Office on Drugs and Crime and the 
International Narcotics Control Board to assist in the implementation of actions taken 
within the framework of national and regional cooperation mechanisms;
 (j) Support the United Nations Office on Drugs and Crime and the International 
Narcotics Control Board in conducting, coordinating and disseminating research on 
precursors in collaboration with the international scientific community to understand 
emerging trends;
 (k) Emphasize the importance of the instruments provided for in article 12 of 
the 1988 Convention and promote and further enhance their effective implementation,30 
and also maintain secure means of communication, including secure e-mail 
addresses;
 (l) Endeavour to compile national lists of companies authorized to manufacture, 
distribute and/or trade in precursors, with a view to enhancing means of verification;
 (m) Strengthen national capacity to provide forensic support to law enforcement 
and the criminal justice authorities in investigating offences involving precursor chemi-
cals, including their trafficking, diversion and use in clandestine laboratories, and assist 
law enforcement authorities in the detection of precursors on the ground and the early 
identification of new trends;
 (n) Enhance frameworks for the exchange of high-quality and reliable forensic 
information among drug control agencies, customs authorities and police authorities, 
including, when appropriate, through the United Nations Office on Drugs and Crime 
forensic laboratory;
30
 The use of the Pre-Export Notification Online system, including the provision of a timely response, 
is a key issue in this respect. On a voluntary basis, that system may be used for reporting, to the extent 
possible and in accordance with national authorities, non-scheduled substances, including pharmaceutical 
preparations, prior to export, and transit countries should be notified.
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 (o) Determine estimates of their legitimate national requirements for ephedrine, 
pseudoephedrine, 3,4-methylenedioxyphenyl-2-propanone and 1 phenyl-2-propanone, 
as endorsed by the Commission on Narcotic Drugs in its resolution 49/3, and provide 
that information to the International Narcotics Control Board, which, in consultation 
with Member States, should seek to promote standardized methodologies to assist with 
those estimates to the fullest extent possible;
 (p) Strengthen national and regional cooperation among drug control agencies, 
customs authorities, police authorities, forensic laboratories, relevant industries and 
operators along the supply chain with a view to preventing the diversion of precursor 
chemicals;
 (q) Make better use of international collaborative and cooperative mechanisms 
and new and developing technologies to support effective national and international 
control measures, including the production of strategic data on precursor trends (includ-
ing information on diversions, as well as on clandestine manufacturing methods and 
starting materials currently being used in clandestine laboratories);
 (r) Develop systems (for example, shared online recording systems) to prevent 
precursor chemicals from being diverted into illicit channels from community 
pharmacies;
 (s) Increase efforts, beyond international trade controls, to prevent the diversion 
of precursors, and pharmaceutical preparations containing the precursors ephedrine and 
pseudoephedrine, from domestic channels to be smuggled across borders, while stress-
ing that the increased involvement of border control authorities in this respect is 
essential;
 (t) Develop practical procedures for the safe handling and disposal of seized 
precursors in cooperation with competent international and regional bodies and share 
experiences in that area, as well as training and related activities;
 (u) Consider “marking” certain chemical shipments for possible future use if 
scientific advances ensure the appropriate use of such tools, taking into account the 
potential burden this would place on authorities and industry;
 (v) Continue to support the successes achieved under Project Prism and Project 
Cohesion, which underline the importance of such activities, including the vital and 
indispensable role of the International Narcotics Control Board as the global focal 
point.
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D.  international cooperation on eradicating the illicit cultivation of 
crops used for the production of narcotic drugs and psychotropic 
substances and on alternative development31
1. strengthening research, data-collection and assessment tools
Problem
42. The generation, distribution, sharing and use of credible information on alternative 
development, including, where appropriate, preventive alternative development, 
are essential to support the drafting, implementation, monitoring and evaluation of 
alternative development interventions. However, there continues to be a lack of reliable 
and up-to-date data on illicit drug crop cultivation, including on, inter alia, the drivers 
of illicit crop cultivation, no increase in and ineffective utilization of data on human 
development and socio-economic aspects and insufficient sharing of best practices and 
lessons learned among the members of the international community engaged in alterna-
tive development.
Action
43. Member States should:
 (a) Undertake further research, strengthen data collection and guide better 
alternative development programmes;
 (b) Conduct research to assess the factors leading to the illicit cultivation of 
drug crops used for the production of narcotic drugs and psychotropic substances;
 (c) Provide the necessary financial and political support, to the extent possible, 
to survey, monitor and verify the extent of coca bush, opium poppy and cannabis cul-
tivation, both in indoor and outdoor cultivation sites, consistent with international drug 
control conventions, and share this information with relevant international agencies and 
other Governments with a view to increasing cooperation on drug crop eradication and 
on alternative development, including, where appropriate, on preventive alternative 
development, in accordance with the specificities of each country or region;
 (d) Ensure that States with the necessary expertise, the United Nations Office 
on Drugs and Crime and other relevant United Nations organizations assist affected 
States in designing and improving systems to monitor and assess the qualitative 
and quantitative impact of alternative development and drug crop eradication 
programmes with respect to the sustainability of illicit crop reduction and socio- 
31
 In accordance with Economic and Social Council resolutions 2006/33, 2007/12, annex, and 
2008/26, the concept of alternative development includes preventive alternative development.
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economic development; such assessment should include the use of human 
development indicators that reflect the Millennium Development Goals;
 (e) Ensure that affected States, the United Nations Office on Drugs and Crime 
and other relevant key actors strengthen efforts to share the results of alternative devel-
opment programmes with the broader development community; in that regard, increased 
efforts should be made to highlight the work accomplished and the benefits provided 
to affected communities, and best practices and lessons learned should be identified 
and shared, failures evaluated and conclusions disseminated to the broader development 
community.
2. international cooperation on development-oriented drug control
Problem
44. Despite considerable advances over the past 10 years in strengthening international 
cooperation to address illicit drug crop cultivation through alternative development, the 
problem of ensuring increased and sustained financial, technical and political assistance 
by States and the international community continues to hinder the full applicability of 
alternative development. As such, increased cooperation among States and the interna-
tional community, under the principle of shared responsibility, a balanced approach and 
the framework of sustainable development, with a specific focus on preventing, reducing 
and eliminating the illicit cultivation of crops used for the production of narcotic drugs 
and psychotropic substances, is necessary to achieve effective and sustainable 
programmes.
Action
45. Member States should:
 (a) Foster and strengthen international cooperation based on the principle of 
shared responsibility in sustainable alternative development, including, where appropri-
ate, preventive alternative development;32
 (b) Reinforce international assistance in addressing the eradication of illicit 
drug crop cultivation and illicit drug production through integrated and sustainable 
alternative development; in this connection, long-term political and financial commit-
ments on the part of Governments and the international community should be promoted 
to the extent possible;
 (c) Establish, where possible, sustainable alternative development programmes, 
in particular in drug-producing regions, including those with high levels of poverty, as 
32
 Economic and Social Council resolution 2007/12, annex, para. 18 (c).
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they are more vulnerable to exploitation by traffickers and more likely to be affected 
by the illicit cultivation of drug crops and the illicit production of and trafficking in 
narcotic drugs and psychotropic substances;
 (d) Consider, where appropriate, including in their national development strate-
gies, integrated and sustainable alternative development programmes, recognizing that 
poverty and vulnerability are some of the factors behind illicit drug crop cultivation and 
that poverty eradication is a principal objective of the Millennium Development Goals; 
and request development organizations and international financial institutions to ensure 
that alternative development strategies, including, when appropriate, preventive alterna-
tive development programmes, are incorporated into poverty reduction strategy papers 
and country assistance strategies for States affected by the illicit cultivation of crops 
used for the production of narcotic drugs and psychotropic substances;
 (e) Support the United Nations Office on Drugs and Crime so that it can con-
tinue to exercise its catalytic role with a view to mobilizing technical, financial and 
political support from international financial institutions, non-governmental organiza-
tions, relevant United Nations organizations, the private sector and civil society and so 
that it can also continue its work in supporting States in the design, implementation, 
monitoring and evaluation of alternative development programmes;
 (f) Ensure that the design and implementation of alternative development 
programmes, including, when appropriate, a preventive approach, involve all stakehold-
ers, take into account the specific characteristics of the target area and incorporate 
grass-roots communities in project formulation, implementation and monitoring;
 (g) Ensure that international and regional agencies working on alternative 
development engage in dialogue in order to strengthen inter-agency cooperation while 
respecting each organization’s role and mandate;
 (h) Promote plans, strategies and guiding principles among members of the 
development community, in particular international financial institutions, to integrate 
measures to address the causes of the illicit cultivation of crops used for the production 
of narcotic drugs and psychotropic substances and to incorporate alternative develop-
ment strategies into their wider development agendas where such strategies do not al-
ready exist;
 (i) Ensure, in collaboration with multilateral agencies and international and 
regional financial institutions, that short-, medium- and long-term planning allows for 
the continuous financial support of integrated and sustainable alternative development 
programmes, including preventive alternative development programmes where appro-
priate, particularly in vulnerable areas;
 (j) Take into account, where appropriate, governance and security concerns 
when implementing alternative development programmes, highlight, where appropriate, 
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the status of national drug control strategies and programmes, including the eradication 
of illicitly cultivated crops used for the production of narcotic drugs and psychotropic 
substances and ensure that a balanced approach to national drug control and alternative 
development strategies is adequately applied;
 (k) Reach out to States not affected by illicit drug crop cultivation and to the 
private sector with a view to providing greater access to markets for alternative develop-
ment products, consistent with national and international obligations and taking into 
account applicable multilateral trade rules;
 (l) Make use of existing cooperation mechanisms and develop regional coop-
eration mechanisms to exchange experiences in the areas of alternative development 
and eradication of illicitly cultivated crops used for the production of narcotic drugs 
and psychotropic substances;
 (m) Assist States affected by illicit drug crop cultivation to strengthen cross 
border, subregional and regional technical assistance and cooperation, including South-
South cooperation; and request the United Nations Office on Drugs and Crime, the 
international development community and other key stakeholders to promote and sup-
port relevant cooperation in this regard;
 (n) Cooperate with development partners to harmonize, align and manage in-
ternational development assistance provided to the States affected by illicit drug crop 
cultivation in accordance with the principles of the 2005 Paris Declaration on Aid 
Effectiveness: Ownership, Harmonization, Alignment, Results and Mutual 
Accountability;
 (o) Encourage relevant international financial institutions, United Nations or-
ganizations, non-governmental organizations and the private sector to increase their 
rural development support for regions and populations affected by illicit drug crop 
cultivation through long-term and flexible funding, and, to the extent possible, affected 
States should make a stronger commitment to financing alternative development 
programmes.
3.  a balanced, long-term approach to addressing the illicit cultivation of crops used 
for the production of narcotic drugs and psychotropic substances
Problem
46. Despite some significant progress made in certain areas, efforts have not led to 
a significant overall decrease in the global illicit cultivation of crops used for the 
production of narcotic drugs and psychotropic substances. The lack of understanding 
of demand/supply drug market dynamics and the lack of a long-term balanced approach, 
combined with ill-sequenced policy interventions, corruption and inadequate 
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international development assistance to address the causes driving illicit crop culti-
vation, have impeded the ability of Governments to sustain the gains achieved 
locally.
Action
47. Member States should:
 (a) Tackle alternative development in a larger development context through a 
holistic and integrated approach, taking into account the Millennium Development 
Goals, with the priority of eradicating poverty;
 (b) Develop alternative development programmes and eradication measures 
while fully respecting relevant international instruments, including human rights instru-
ments, and, when designing alternative development interventions, taking into consid-
eration the cultural and social traditions of participating communities;
 (c) Ensure that development assistance provided to communities in areas af-
fected by illicit cultivation of crops used for the production of narcotic drugs and 
psychotropic substances takes into account the overall aims of human rights protection 
and poverty eradication;
 (d) Ensure that the implementation of alternative development and preventive 
alternative development, as appropriate, enhances synergy and trust among the national 
Government, local administrations and communities in building local ownership; 
 (e) Integrate communities in marginalized regions into the economic and politi-
cal mainstream in order to further drug control efforts and security; if appropriate, such 
integration should include the possibility of supporting access to roads, schools, primary 
health-care services, electricity and other services and infrastructure;
 (f) Ensure the proper and coordinated sequencing of development interventions 
when designing alternative development programmes; and, in this connection, the issues 
of the establishment of agreements and viable partnerships with small producers, fa-
vourable climatic conditions, strong political support and adequate market access should 
be taken into account; 
 (g) Ensure, when considering taking eradication measures, that small-farmer 
households have adopted viable and sustainable livelihoods so that the measures may 
be properly sequenced in a sustainable fashion and appropriately coordinated;
 (h) Support, in particular in collaboration with development partners, inter-
national financial institutions and the United Nations Office on Drugs and Crime, within 
its mandate, States engaged in alternative development by carrying out preventive 
alternative development activities, where appropriate, or proactive development 
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measures to prevent the expansion of the illicit cultivation of crops used for the produc-
tion of narcotic drugs and psychotropic substances and the migration of workers to areas 
affected by illicit drug crop cultivation and illicit drug production zones;
 (i) Ensure that development partners, international financial institutions and 
the United Nations Office on Drugs and Crime support States in addressing the illicit 
cultivation of coca bush, opium poppy and cannabis through sequenced activities, such 
as conducting further research to assess the extent of cultivation, identifying the social 
and economic drivers of cultivation and, ultimately, designing appropriate interventions 
to tackle the problem;
 (j) Address the need to enhance international cooperation and increase com-
prehensively the effectiveness of strategies aimed at strengthening the capacity of States 
to counter illicit cultivation of crops used for the production of narcotic drugs and 
psychotropic substances and at promoting the realization of alternative development 
programmes;
 (k) Develop market infrastructure in support of alternative development pro-
grammes, sharing best practices among Governments and regions, as appropriate;
 (l) Promote a coordinated response to alternative development and 
eradication;
 (m) Implement, where there is illicit cultivation of crops used for the production 
of narcotic drugs and psychotropic substances, comprehensive multisectoral interven-
tions that take into account social, cultural, economic, political, educational and envi-
ronmental aspects while incorporating, where appropriate, demand reduction 
measures;
 (n) Mainstream drug control and alternative development approaches into the 
broader development agenda, while encouraging the development community, in par-
ticular the international financial institutions, to incorporate drug control approaches 
into their wider development agendas.
4. innovative strategies to support alternative development 
Problem
48. Emerging threats and new challenges competing for global attention have led to 
a significant reduction in the means available to support the implementation of alterna-
tive development programmes, including preventive alternative development pro-
grammes, where appropriate. There is an increasing need to identify new and innovative 
funding mechanisms and to ensure that alternative development programmes are com-
plementary to and incorporated into programmes aimed at addressing environmental 
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issues. Likewise, the identification of market-driven products must be undertaken with 
the private sector, and market access must be assured in order to effectively implement 
alternative development strategies. 
Action
49. Member States should:
 (a) Encourage all Member States and multilateral, international and regional 
financial institutions, in conformity with the principle of shared responsibility, to re-
double their efforts to enhance international cooperation, aimed at utilizing the expertise 
of developing countries and the financial support of developed countries in assisting 
developing countries, to reduce the illicit cultivation of drug crops through alternative 
development and preventive alternative development, as appropriate;
 (b) Develop strategies consistent with domestic legal frameworks, including 
the utilization of local expertise, capacity-building and entrepreneurship, to develop 
products through alternative development programmes identified on the basis of market 
demand and value-added production chains, as well as secure and stable markets with 
fair prices for producers, in accordance with international trade rules, including the 
required infrastructure and a conducive environment, including roads, the establishment 
of farmer associations and the use of special marketing regimes, for example those 
based on fair-trade principles and commerce in organic products;
 (c) Consider supporting public information campaigns to raise awareness about 
the concept of shared responsibility and about the added social value of alternative 
development products;
 (d) Assist States affected by the illicit cultivation of crops used for the produc-
tion of narcotic drugs and psychotropic substances to take advantage of existing mecha-
nisms, such as debt swaps, and existing trade arrangements, and to explore the possibility 
of increasing national financing for alternative development programmes;
 (e) Ensure that development partners, affected States and other relevant key 
development actors examine innovative ways to promote alternative development pro-
grammes, including preventive alternative development programmes, where appropriate, 
that are environmentally friendly;
 (f) Continue to promote gender equality in alternative development inter-
ventions, ensuring that equal conditions exist for full participation in the design, 
implementation and evaluation of alternative development programmes;
 (g) Encourage participatory approaches from all stakeholders, including groups 
at risk of starting to illicitly cultivate crops used for the production of narcotic drugs 
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and psychotropic substances, in the identification, preparation, implementation, moni-
toring and evaluation of alternative development;
 (h) Support, together with development partners, affected States and other 
relevant development agencies, the institutional strengthening of key national line agen-
cies involved in alternative development, particularly national drug control coordinating 
bodies, recognizing that the sustainability of programmes depends on strengthened 
national institutions and their ability to bring together Government agencies and to 
coordinate with the international community;
 (i) Examine the possibility of supporting regional mechanisms and promoting 
bilateral agreements between States in order to address the problem of geographical 
displacement.
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Part iii.  countering money-laundering and promoting  
judicial cooperation to enhance international 
cooperation
e. countering money-laundering
Problem
50. The laundering of money derived from illicit drug trafficking and other serious 
crimes continues to be a global problem that threatens the security and stability of 
financial institutions and systems, undermines economic prosperity and weakens 
governance systems. 
Action
51. Member States should continue to foster international cooperation by implement-
ing the provisions against money-laundering contained in all relevant international and 
multilateral instruments, such as the 1988 Convention, the Organized Crime Convention 
and the Convention against Corruption and, in accordance with national legislation, the 
Financial Action Task Force Recommendations on Money Laundering, and also by:
 (a) Establishing new or strengthening existing domestic legislative frameworks 
to criminalize the laundering of money derived from drug trafficking, precursor diver-
sion and other serious crimes of a transnational nature in order to provide for the pre-
vention, detection, investigation and prosecution of money laundering by, inter alia:
 (i)  Widening the scope of predicate crimes for money-laundering to include 
all serious crimes, giving due consideration to crimes related to the misuse 
of new technologies, cyberspace and electronic money transfer systems and 
to transnational cash smuggling;
 (ii)  Adopting or strengthening legal measures providing for the identification, 
freezing, seizure and confiscation of the proceeds of crime and considering, 
where compatible with fundamental principle of domestic law, non- 
conviction-based confiscation;
 (iii)  Promoting the use of internationally accepted asset-sharing procedures in 
international confiscation cases, such as the Model Bilateral Agreement on 
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the Sharing of Confiscated Proceeds of Crime or Property, adopted by the 
Economic and Social Council in its resolution 2005/14;
 (iv)  Ensuring that legal provisions in compliance with due process of law, such 
as banking secrecy laws, do not unnecessarily impede the effectiveness of 
their systems for countering money-laundering and do not constitute 
grounds for the refusal of mutual legal assistance; 
 (v)  Granting the widest range of mutual legal assistance in investigations, 
prosecutions and other judicial proceedings related to money-laundering 
and confiscation cases; 
 (vi)  Ensuring that the crime of money-laundering is covered by mutual legal 
assistance agreements for the purpose of ensuring judicial assistance in 
investigations, court cases and other judicial proceedings relating to that 
crime; 
 (vii)  Making money-laundering an extraditable offence, in accordance with 
national legislation;
 (b) Establishing new or strengthening existing financial and regulatory regimes 
for banks and non-bank financial institutions, including natural and legal persons pro-
viding formal or informal financial services, thus preserving the integrity, reliability 
and stability of financial and trade systems through, inter alia:
 (i)  Customer identification and verification requirements, namely, application 
of the “know-your-customer” principle in order to have available for com-
petent authorities the necessary information on the identity of clients and 
their financial transactions; 
 (ii)  Requirements for the submission of meaningful beneficial ownership in-
formation for legal persons;
 (iii)  Financial record-keeping; 
 (iv)  The mandatory reporting of suspicious transactions; 
 (v)  Mechanisms to detect and monitor the cross-border transport of cash and 
other negotiable bearer instruments;
 (vi)  Consideration of establishing partnerships with the private sector, including 
financial businesses, with a view to ensuring sound and effective due- 
diligence procedures to counter money-laundering; 
 (vii)  The introduction of measures to keep centralized statistical data on legal 
action taken to counter money-laundering;
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 (c) Implementing effective detection, investigation, prosecution and conviction 
measures, including:
 (i)  The establishment of dedicated financial intelligence units to serve as na-
tional centres for the collection, analysis and dissemination of suspicious 
transaction reports and the consideration of existing and affordable informa-
tion technology solutions to assist financial intelligence units in the analysis 
of suspicious transaction reports;
 (ii)  The development of specialized law enforcement techniques, consistent 
with national legislative frameworks, to support efforts to counter money 
laundering;
 (iii)  The encouragement of specialized training for law enforcement and judicial 
personnel in techniques for countering money-laundering; 
 (iv)  The consideration, in conformity with domestic legislation, of utilizing 
confiscated funds to support law enforcement activities, demand reduction 
programmes and efforts to counter money-laundering;
 (v)  The development and use of instruments to detect and counter, in a timely 
manner, emerging methods and techniques for laundering money, including 
money derived from drug trafficking, from the diversion of precursors and 
from the abuse of cyberspace, money transfer systems and payment cards; 
and the provision of technical assistance for building the capacity of 
developing countries in this regard, including the development of national 
detection instruments;
 (d) Promoting effective cooperation in strategies for countering money- 
laundering and in money-laundering cases by, inter alia: 
 (i)  Strengthening mechanisms for domestic inter-agency coordination and 
information-sharing; 
 (ii)  Strengthening regional and international networks for the exchange of 
operational information among competent authorities, in particular financial 
intelligence units; 
 (iii)  Avoiding, to the extent possible, the duplication of data-collection tools 
related to Member States’ obligations with respect to countering money- 
laundering, as set out in relevant United Nations instruments.
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f. Judicial cooperation
1. extradition 
Problem
52. Legal impediments to extradition and practical difficulties remain, even though 
most States have laws in place and have entered into bilateral and multilateral treaties 
on the extradition of drug offenders, and many States have revised their legislation since 
the twentieth special session of the General Assembly. Concerning the non-extradition 
of nationals, several States maintain the position that they will not consider extraditing 
their nationals.
53. Much progress has been achieved through the adoption of relevant bilateral, 
regional and international agreements, especially at the regional level. While the low 
number of reported refusals is encouraging, there remain many difficulties with regard 
to differences between legal systems, delays and procedural and language problems.
Action
54. Member States should:
 (a) Make full use of multilateral treaties, notably, the 1988 Convention, the 
Organized Crime Convention and the Convention against Corruption, subject to their 
constitutional and judicial provisions and consistent with relevant international law, as 
a legal basis for requesting and granting extradition as a supplement to bilateral and 
regional treaties on judicial cooperation;
 (b) Make use of the 1988 Convention, the Organized Crime Convention and 
the Convention against Corruption, as appropriate, for the purpose of providing a basis 
for establishing dual criminality required for drug offences, in accordance with their 
national legislation;
 (c) Establish mechanisms to facilitate extradition in line with the international 
drug control conventions, subject to their national legislation, specifically by considering 
further simplification of requirements in such areas as dual criminality, the application 
of political offences, consent surrender and conditional surrender;
 (d) Ensure that when, on grounds of nationality, they do not extradite a person, 
they submit, in conformity with their domestic legislation, as appropriate, the case to 
their competent national authorities for prosecution;
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 (e) Advance cooperation in the areas of extradition, mutual legal assistance 
and law enforcement, as well as the effective use of tools and programmes to enhance 
cooperation efforts, consistent with relevant and applicable international human rights 
obligations and in accordance with their national legislation;
 (f) Adopt measures to expedite extradition procedures and simplify evidentiary 
requirements in conformity with their domestic laws. 
2. mutual legal assistance
Problem
55. While most States have adopted legislation and entered into bilateral and multi-
lateral treaties on mutual legal assistance in drug trafficking cases, and many have revised 
their procedures since the twentieth special session of the General Assembly, it is dif-
ficult to assess the rate of implementation of those provisions. While some progress has 
been made in this area, problems remain, particularly in relation to differences in pro-
cedural requirements, the protection of bank secrecy, the protection of national interests, 
translation requirements and delays. Statistics on requests for mutual legal assistance 
are also lacking.
Action
56. Member States should:
 (a) Make full use of multilateral treaties, notably the 1988 Convention, the 
Organized Crime Convention and the Convention against Corruption, subject to their 
constitutional provisions, as a legal basis for requesting and granting mutual legal as-
sistance and as a supplement to bilateral and regional treaties on judicial cooperation;
 (b) Consider the adoption of a more flexible approach to judicial cooperation 
in order to facilitate the provision of the widest possible range of mutual legal assist-
ance, in particular in the area of non-coercive measures;
 (c) Maintain timely and clear communication among all central authorities, 
with particular attention to regular consultations with States that have a high volume of 
requests for assistance, and undertake prior consultations in complex or time-sensitive 
cases;
 (d) Ensure that procedures and practices in relation to mutual legal assistance, 
extradition and controlled delivery capacity between States take account of different 
legal systems; and consider, where appropriate, the posting of criminal justice liaison 
personnel abroad;
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 (e) Request the United Nations Office on Drugs and Crime, in cooperation with 
Member States, to consider the advisability and feasibility of establishing a virtual 
network of central authorities for mutual legal assistance and competent authorities for 
extradition requests, pursuant to the 1988 Convention and the Organized Crime 
Convention, in order to facilitate communication and problem solving among such 
authorities.
3. transfer of proceedings
Problem
57. A limited number of States have entered into bilateral and multilateral agreements 
or revised their legislation to facilitate the transfer of proceedings. The availability of 
data was lower than in other areas.
Action
58. Member States should:
 (a) Consider adopting legislation or procedures to enable the transfer of pro-
ceedings, where appropriate, in particular where extradition is not possible;
 (b) Make available information on their experiences in the transfer of proceed-
ings to interested States if they have had such experiences;
 (c) Consider entering into agreements with other States to transfer or receive 
proceedings in criminal matters, particularly with those States which do not extradite 
their nationals and, in that connection, refer to the Model Treaty on the Transfer of 
Proceedings in Criminal Matters33 as a basis for negotiation.
4. controlled delivery
Problem
59. Practical difficulties remain in the implementation of controlled delivery. Some 
of the difficulties relate to differences in legal provisions and authorities responsible 
for conducting controlled deliveries in different States, as well as to identifying the links 
between local and international criminal groups.
33
 General Assembly resolution 45/118, annex.
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Action
60. Member States should:
 (a) Ensure, if permitted under the basic principles of their legal systems, that 
legislation, procedures and practices allow for the use of controlled delivery at the 
national and international levels and, to that end, enter into necessary agreements, 
arrangements and understandings;
 (b) Enhance cooperation in the areas of controlled delivery requirements, na-
tional capacities and sharing of information pertaining to controlled delivery, in con-
formity with domestic law;
 (c) Improve and consider institutionalizing the exchange of information among 
source, transit and destination countries and among intergovernmental organizations in 
the area of law enforcement cooperation; States, in particular those situated along major 
drug trafficking routes, should, in conformity with their national legislation, consider 
establishing joint investigations and teams of law enforcement officers dealing with 
drug trafficking and organized crime.
5. witness protection
Problem
61. Disparities remain among States with respect to legislative provisions, rules, 
procedures and capacities for the protection of witnesses.
Action
62. Member States should take appropriate measures, within their means, including 
adopting, where they have not yet done so, legislation, rules and practical measures that 
provide for the protection of witnesses before, during and after trial and that allow, 
where appropriate, the implementation of measures consistent with those set out in the 
Organized Crime Convention, which should be used to the fullest extent possible, as it 
includes state-of-the-art measures in this area.
6. complementary measures
Problem
63. Although legal and procedural frameworks exist in many States, numerous dif-
ficulties remain in the implementation of all the measures, in particular the legal, pro-
cedural and technical aspects with respect to the execution of requests for judicial 
cooperation.
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Action
64. Member States should:
 (a) Identify areas of synergy between the work of the United Nations Office 
on Drugs and Crime on judicial cooperation in the area of drug trafficking in the context 
of the 1988 Convention and the work carried out to implement the Organized Crime 
Convention and the Convention against Corruption, recognizing that gathering informa-
tion on the implementation of those instruments must be complementary and mutually 
supportive;
 (b) Assist the United Nations Office on Drugs and Crime in expanding online 
tools, such as the directory of designated authorities, to enable the sharing of judicial 
cooperation tools, including model forms, guidelines and manuals for extradition, mutual 
legal assistance, transfer of proceedings and other types of judicial cooperation or include 
links to websites containing such information; 
 (c) Enable the United Nations Office on Drugs and Crime to assist them, upon 
request, in collecting data for international cooperation and, where appropriate, in es-
tablishing databases to maintain such information;
 (d) Use, in conformity with national legislation, existing tools and programmes 
to enhance extradition and mutual legal assistance through information-gathering, ju-
dicial assistance resources, including online resources such as directories, model forms, 
guidelines and manuals;
 (e) Promote training and workshops to help acquaint States with different legal 
systems and strengthen working relationships among counterparts in order to facilitate 
the execution of requests for assistance and build trust among central authorities;
 (f) Strengthen the role of the United Nations Office on Drugs and Crime in 
providing training and in facilitating problem-solving forums in recognition of the need 
for States to familiarize themselves with different legal systems and to establish new 
or strengthen existing working relationships with counterparts; 
 (g) Review national legislation, as appropriate, to ensure compliance with the 
legal requirements of the 1988 Convention, as well as to promote the exchange of in-
formation among competent authorities regarding drug trafficking by sea, through re-
gional and subregional cooperation;
 (h) Define the liability and responsibilities of various shipping structures and 
strengthen cooperation with professional trade associations, consistent with existing 
international mechanisms and in accordance with their national legislation.
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